Eyeworld

Archives EyeWorld.org EyeWorldTV.com EyeWorld ASCRS•ASOA SYMPOSIUM & CONGRESS, SAN DIEGO 2015 digital.eyeworld.org EyeWorld Daily News • The official ASCRS•ASOA Show Daily P remium IOLs can offer advantages to all patients, including those with glau- coma, but patient selection is key, said Richard Lewis, MD, Sacramento, California, at ASCRS Glaucoma Day. Physicians must use modern IOL formulas and avoid multifocal IOLs in glaucoma patients with cupping or visual loss, he added. The decision regarding a pre- mium lens in patients with glauco- ma should include a review of the patient's visual needs, the role of glasses in his or her life, and glauco- ma status. Saturday, May 6, 2017 continued on page 5 Luther Fry, MD Dr. Lewis discusses premium IOLs for glaucoma patients at Glaucoma Day. Connection between glaucoma, cataract surgery a focus at Glaucoma Day Honored Guests bring their expertise to this year's ASCRS meeting L uther Fry, MD, Garden City, Kansas, and Y.C. Lee, MD, Perak, Malaysia, are Hon- ored Guests of ASCRS and the Asia-Pacific Association of Cataract & Refractive Surgeons (APACRS) at this year's meeting. At today's ASCRS Opening General Ses- sion, they will be honored for their contributions to ophthalmology. Dr. Fry is the founder of Fry Eye Associates in Garden City. He is a clinical assistant professor in the De- partment of Ophthalmology at the University of Kansas Medical Center. Previously named as one of the "Best Doctors in America," Dr. Fry specializes in cataract extraction and intraocular lens implantation. He has performed more than 32,000 cataract surgeries. He is board certified by the American Board of Ophthalmolo- gy. He is also certified in cataract surgery by the American Board of Eye Surgeons. He is a member of the board of directors for the Ophthal- mic Anesthesia Society and is a past president of the society. He is also a member of the board of directors for the American College of Eye Sur- geons and is its past president. Dr. Fry received his medical degree from the University of Kansas Medical School and completed Y.C. Lee, MD Dr. Lewis reminded attendees that IOL calculation formulas have advanced tremendously in the past 10 years, with the recent addition of effective lens position to the formula mix. The use of a current IOL calculation formula is crucial, he said. Dr. Lewis briefly addressed pros and cons of both multifocal and toric IOLs. Despite the advantages of toric IOLs, "I'm always surprised at how few glaucoma surgeons put them in," he said. As glaucoma patients are more likely to have pupil issues, surgeons should be ready to medically man- continued on page 5 age this problem or use devices like a Malyugin ring or capsular tension ring. Surgeons should also aim to minimize the risk glaucoma patients have for cystoid macular edema. Femtosecond laser-assisted cataract surgery generates a lot of clinical interest, and Leon Hern- don, MD, Durham, North Carolina, addressed whether it's a technology that glaucoma surgeons should use when they perform cataract surgery. He concluded that most glaucoma patients are candidates for it except for those with poorly controlled IOP, severe glaucoma, or poor dilation. Despite its advantages, it's not yet by Vanessa Caceres EyeWorld Contributing Writer Dr. Lindstrom delivers the second annual Steinert Lecture at Refractive Day. continued on page 3 by Liz Hillman EyeWorld Staff Writer T he second annual ASCRS Refractive Day addressed corneal and lens-based refractive surgery and featured the notable Steinert Lecture given by Richard Lindstrom, MD, Minneapolis. Though Roger Steinert, MD, died in June 2017 after battling glio- blastoma, David Chang, MD, Los Altos, California, said his spirit lives on in the annual ASCRS Refractive Day Steinert Lecture. "So much can happen in so little time and impermanence is a circumstance we all must endure," April Steinert, Dr. Steinert's wife, said, introducing the lecture. "Today it may appear that I stand up here alone, but I assure you that is not the case. Roger is here in this room with us," she continued. Mrs. Steinert went on to intro- duce Dr. Lindstrom, listing his many accomplishments and highlighting his longtime friendship with Dr. Steinert. In the lecture, Dr. Lindstrom shared his thoughts on the current state of laser refractive surgery. Though LASIK reached its high in the late 1990s and early 2000s, after 9/11 and then the Great Recession there was a decline in the elective procedure from which it has not yet recovered. digital.eyeworld.org Saturday, April 14, 2018 EyeWorld Daily News • The official ASCRS•ASOA Show Daily Steinert Lecture a highlight of second annual ASCRS Refractive Day Dr. Rhee came out on top in the Glaucoma Fighting Championship debate against Dr. Ahmed on the question "Is trabeculectomy dead?" by Liz Hillman EyeWorld Staff Writer Glaucoma Fighting Championship rematch: 'Is trabeculectomy dead?' Doug Rhee, MD, argues trab is alive, remains reigning GFC champ D ouglas Rhee, MD, Cleveland, remains the undefeated champ of the Glaucoma Fighting Championship (GFC) in a rematch debate against Iqbal "Ike" Ahmed, MD, Toronto, Canada, over whether trabeculectomy is dead. The challengers of the Glauco- ma Day event, refereed by Steven Sarkisian, MD, Oklahoma City, pulled no punches, at least not lit- erally, but didn't hold back on their snarky jibes toward each other or their own pithy arguments in favor of their position. Dr. Rhee, starting off in the blue corner, argued that trabeculectomy is not dead and Dr. Ahmed in the red corner gave his thoughts to the contrary. Dr. Ahmed, as the challenger, started off the debate. Microinvasive glaucoma surgery (MIGS), subcon- junctival microstents and better continued on page 6 F R I DAY, J U LY 2 3 , 2 0 2 1 | A S C R S A N N UA L M E E T I N G DAILY NEWS EyeWorld: What was it like com- ing on as ASCRS president at the beginning of the pandemic? Dr. Kim: As I was taking on my role as president, I never imag- ined I'd face the immediate challenges that our organization had to face, but I was prepared to take on that challenge. I was thankful to have a strong and supportive organization in terms of the ASCRS staff, executive director, Executive Committee, and Governing Board to help nav- igate through the difficulties. For anyone dealing with this crisis, it was a dynamic, ever-evolving situ- ation; it was never just one thing. There were adjustments that were constantly being made in terms of our clinical care protocols, edu- cational offerings, governmental relief initiatives, and communica- tion with members. continued on page 4 continued on page 3 FOR MORE INFORMATION, VISIT US AT BOOTH #5201 SO YOUR PATIENTS DON'T HAVE TO © 2021 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA is a registered trademark of Ocular Therapeutix, Inc. PP-US-DX-0323 OT_ASCRS_Daily_News_Banner_MECH_07Jul2021.indd 4 OT_ASCRS_Daily_News_Banner_MECH_07Jul2021.indd 4 7/14/21 11:28 AM 7/14/21 11:28 AM Visit Booth 5208 to Hear What's New at BVI BVI and all other trademarks (unless noted otherwise) are property of BVI. BVI ©2021 Outgoing ASCRS president reflects on unprecedented year A Q&A with ASCRS president Richard Hoffman, MD R ichard Hoffman, MD, the current ASCRS president, has been involved with ASCRS, EyeWorld, and the Journal of Cataract & Refractive Surgery for years. He shared his thoughts on his presidency and his vision for the society. T erry Kim, MD, served as ASCRS president during a year full of unprecedent- ed challenges brought on by the COVID-19 pan- demic. He reflected on his year as president, the challenges and how ASCRS addressed them, import- ant initiatives, and more. EyeWorld: How and when did you first become involved with ASCRS? Dr. Hoffman: I became involved with ASCRS in the mid-1990s, in part due to the work my part- ner, Howard Fine, MD, had been doing with ASCRS. Howard was teaching at meetings and in- volved in the Governing Board and Executive Committee and Daily News SUPPLEMENT TO EYEWORLD AUGUST 2020 ASCRS by Vance Thompson, MD Turning the Lights Back On Supported by Alcon Ophthalmology as a medical specialty has been hit hard in the COVID-19 pandemic, and ophthalmic practices have just started to regain their sea legs, figuring out how to steady themselves amid the safety concerns, financial hardships, and other unknowns. The 2020 ASCRS Virtual Annual Meeting, which took place May 16–17, featured a two-part special session, Turning the Lights Back On supported by Alcon, to specifically address the unique challenges and opportunities the COVID-19 pandemic presents to ophthalmology. This resource features key content from this session and additional thoughts from notable physicians. P resbyopia patients, even in this COVID-era environment, want to hear about all of the solutions for implant technol- ogy during cataract surgery. In fact, they seem, in my experience, to be even more interested now. We've been amazed at our practice because since reopening for elective surgery, the adoption rate for pre- mium implants has actually been higher than pre-COVID. People seem eager to invest in themselves and their true desires, so they've been open to premium implants, and refractive surgery has been quite popular. Since the ASCRS Virtual Annual Meeting in May, we've seen a significant return in volume. We're back to about 90% of normal, pre-COVID patient volume, and that hap- pened faster than I predicted. Will it be sustainable? That's what we all wonder. what you can do remotely and explain what you can't. The patient journey at our practice has shifted somewhat. Before the pandemic, infor- mation was mailed to patients prior to cataract consulta- tions. They were encouraged to watch an informational video, which many didn't do ahead of time. Now, in order to even set up a telehealth cataract consult, patients have to watch the video. The technician gathers information from the referring doctor for this telehealth visit, preparing a chart for the doctor as they would have if they had been in the office. If a decision is made for an IOL type during the telehealth visit, patients are reminded that this IOL selection could change on surgery day based on certain factors. With so much happening remotely, by the time we get to the surgery day, we're just double checking the numbers, doing the exam and final counseling, then going into surgery. Enhanced safety measures for in-office and OR visits Bringing back refractive cataract surgery Spacing out or blocking chairs in the waiting room and during counseling is one way to help reduce potential exposure among patients and staff. Source: Vance Thompson, MD, screenshot from the 2020 ASCRS Virtual Annual Meeting continued on page 2 While we haven't changed how we counsel patients or how we present them with premium IOL options, there is no question, some elements of "normal" clinic practice have changed—they had to. In the new "normal," pa- tients are very open to remote telemedicine and consults, enabling the doctor to educate them about cataracts and op- tions using existing education- al resources. Advanced testing and the examination, of course, can't currently be done remotely. Patients just want you to do your best. Explain In 2019, ASCRS again conducted its Clinical Survey, which identifies education gaps by compiling data from respondents about their experiences across specialties. The survey in- cluded questions on cataract, refractive, cor- nea, glaucoma, and retina surgery. Information collected is used by ASCRS to guide educational initiatives and activities. The 2019 survey had 1,204 total ASCRS member respondents, with 54.9% practicing in the U.S. and 45.1% practicing elsewhere. Of the respondents, 73.3% were male and 26.7% were female. The survey respondents had a wide range of experience, from those cur- rently in residency or fellowship (11.2%) to those who have been in practice more than 30 years (17.3%). The largest percentage of respondents was those who have been in practice 21–30 years (25.3%), and 64.1% of respondents have been in practice for more than 10 years. Respondents also varied in where they perform surgery, with the largest percentage (32%) performing surgery in a surgeon-owned ASC. CLINICAL SURVEY 2019 HIGHLIGHTS OF THE 2019 ASCRS CLINICAL SURVEY HOW MANY YEARS HAVE YOU BEEN IN PRACTICE? WHERE IS YOUR PRIMARY SURGERY LOCATION? (Select all that apply.) WHERE PRACTICE IS LOCATED MALE VS. FEMALE RESPONDENTS Sponsored by BOOST YOUR REFRACTIVE AND CATARACT SURGERY PRACTICE Innovations for a beer experience and enhanced outcomes SUPPLEMENT TO EYEWORLD DECEMBER 2021 Supplements ASCRS 25 Celebrang OUR SILVER ANNIVERSARY PRESBYOPIA TREATMENT OPTIONS P. 56 FOR SURGEONS. FOR YOU. WWW.EYEWORLD.ORG SEPTEMBER 2021 VOLUME 26, NUMBER 3 News resources

• Cover